Rhinoscleroma

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Rhinoscleroma | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Nasal obstruction, rhinorrhea, epistaxis, dysphonia, dyspnea |
| Complications | Airway obstruction, nasal deformity |
| Onset | Gradual |
| Duration | Chronic |
| Types | N/A |
| Causes | Klebsiella rhinoscleromatis |
| Risks | Poor hygiene, immunosuppression, endemic in certain regions |
| Diagnosis | Biopsy, culture |
| Differential diagnosis | Wegener's granulomatosis, sarcoidosis, leprosy, tuberculosis |
| Prevention | N/A |
| Treatment | Antibiotics (e.g., ciprofloxacin, tetracycline), surgery |
| Medication | N/A |
| Prognosis | Variable, can be chronic |
| Frequency | Rare |
| Deaths | N/A |
Rhinoscleroma is a chronic granulomatous infection that primarily affects the nasal mucosa. It is caused by the bacterium Klebsiella rhinoscleromatis. The disease is characterized by the formation of granulomatous lesions in the nose, which can extend to the upper respiratory tract and mouth.
Etiology[edit]
Rhinoscleroma is caused by the bacterium Klebsiella rhinoscleromatis. This bacterium is a gram-negative, non-motile, encapsulated rod that is part of the Enterobacteriaceae family.
Epidemiology[edit]
Rhinoscleroma is endemic in certain parts of Central and South America, Africa, Eastern Europe, and Asia. It is most commonly seen in individuals between the ages of 10 and 30. The disease is more prevalent in rural areas and in populations with poor sanitation and hygiene.
Clinical Presentation[edit]
The disease typically presents with nasal obstruction, rhinorrhea, and epistaxis. As the disease progresses, it can lead to deformity and destruction of the nasal cartilage and bone. In severe cases, it can extend to the upper respiratory tract and mouth, causing dysphonia, dysphagia, and respiratory distress.
Diagnosis[edit]
Diagnosis of rhinoscleroma is based on clinical presentation, histopathological examination, and microbiological culture. The histopathological examination typically shows granulomatous inflammation with the presence of Mikulicz cells and Russell bodies.
Treatment[edit]
Treatment of rhinoscleroma involves a combination of surgical debridement and long-term antibiotic therapy. The antibiotics of choice are rifampin, ciprofloxacin, and doxycycline.
Prognosis[edit]
The prognosis of rhinoscleroma is generally good with appropriate treatment. However, the disease can cause significant morbidity due to its chronic nature and potential for causing deformity and destruction of the nasal and upper respiratory tract structures.
See Also[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian